Magadan, Melanie .

HRN: 22-90-23  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2023
CEFUROXIME 1.5GM (VIAL)
04/13/2023
04/13/2023
IV
1.5gram
Now
S/p D And C
Waiting Final Action 
04/13/2023
CEFUROXIME 500MG (TAB)
04/14/2023
04/21/2023
ORAL
500mg
BID
S/p D And C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: